Xiangjian Luo

4.7k total citations · 2 hit papers
71 papers, 2.9k citations indexed

About

Xiangjian Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiangjian Luo has authored 71 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 28 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Xiangjian Luo's work include Cancer, Hypoxia, and Metabolism (20 papers), Viral-associated cancers and disorders (17 papers) and RNA modifications and cancer (15 papers). Xiangjian Luo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (20 papers), Viral-associated cancers and disorders (17 papers) and RNA modifications and cancer (15 papers). Xiangjian Luo collaborates with scholars based in China, United States and Saudi Arabia. Xiangjian Luo's co-authors include Ya Cao, Ann M. Bode, Min Tang, Can Cheng, Namei Li, Lifang Yang, Zheqiong Tan, Jianmin Hu, Chaoliang Liao and Huiwen Liu and has published in prestigious journals such as Scientific Reports, FEBS Letters and International Journal of Cancer.

In The Last Decade

Xiangjian Luo

66 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging roles of lipid metabolism in cancer metastasis

2017 499 citations Xiangjian Luo, Can Cheng et al. Molecular Cancer profile →
ACSL family: The regulatory mechanisms and therapeutic implications in cancer

2021 201 citations Ann M. Bode, Xiangjian Luo et al. European Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangjian Luo China	31	1.8k	1.2k	726	387	353	71	2.9k
George G. Chen Hong Kong	31	2.2k 1.2×	1.1k 0.9×	862 1.2×	347 0.9×	397 1.1×	119	3.6k
Yexiong Tan China	35	2.3k 1.3×	1.1k 0.9×	627 0.9×	575 1.5×	347 1.0×	77	3.5k
Zachary T. Schafer United States	23	2.2k 1.2×	1.2k 1.0×	550 0.8×	333 0.9×	350 1.0×	43	3.2k
Franca Esposito Italy	36	2.8k 1.6×	726 0.6×	589 0.8×	293 0.8×	307 0.9×	86	3.8k
Hai‐long Piao China	26	1.9k 1.1×	862 0.7×	348 0.5×	321 0.8×	236 0.7×	75	2.9k
Kristopher K. Frese United Kingdom	17	2.2k 1.2×	797 0.7×	918 1.3×	274 0.7×	298 0.8×	27	3.2k
Zachary T. Schug United States	22	2.3k 1.3×	1.1k 0.9×	443 0.6×	480 1.2×	366 1.0×	37	3.5k
Yun‐Yong Park South Korea	34	2.2k 1.2×	827 0.7×	844 1.2×	258 0.7×	341 1.0×	71	3.5k
Julián Carretero Spain	32	1.8k 1.0×	580 0.5×	638 0.9×	212 0.5×	212 0.6×	59	2.9k

Countries citing papers authored by Xiangjian Luo

Since Specialization

Citations

This map shows the geographic impact of Xiangjian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjian Luo more than expected).

Fields of papers citing papers by Xiangjian Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjian Luo. The network helps show where Xiangjian Luo may publish in the future.

Co-authorship network of co-authors of Xiangjian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjian Luo. A scholar is included among the top collaborators of Xiangjian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjian Luo. Xiangjian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Wenbin, et al.. (2025). The role of fatty acid oxidation in the tumor microenvironment: Implications for cancer progression and therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(6). 189474–189474.

Bode, Ann M., et al.. (2024). Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189166–189166. 10 indexed citations

Bode, Ann M., et al.. (2024). The role of novel protein acylations in cancer. European Journal of Pharmacology. 979. 176841–176841. 6 indexed citations

Li, Yueshuo, Longlong Xie, Feng Shi, et al.. (2024). CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. Cell Death and Disease. 15(1). 95–95. 7 indexed citations

Liu, Huiwen, Xiang Li, Wenbin Liu, et al.. (2024). DHRS2-induced SPHK1 downregulation contributes to the cell growth inhibition by Trichothecin in colorectal carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(8). 119846–119846. 6 indexed citations

Zhu, Haodong, et al.. (2023). The role of circadian clock genes in colorectal carcinoma: Novel insights into regulatory mechanism and implications in clinical therapy. Life Sciences. 333. 122145–122145. 6 indexed citations

Liu, Huiwen, et al.. (2022). The role of circadian clocks in cancer: Mechanisms and clinical implications. Genes & Diseases. 10(4). 1279–1290. 17 indexed citations

Li, Yueshuo, Feng Shi, Jianmin Hu, et al.. (2021). Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication. npj Precision Oncology. 5(1). 14–14. 14 indexed citations

Li, Zhenzhen, Huiwen Liu, Ann M. Bode, & Xiangjian Luo. (2021). Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease. European Journal of Pharmacology. 898. 173972–173972. 15 indexed citations

10.

Shi, Feng, Jiangjiang Li, Min Tang, et al.. (2020). Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis. Molecular Metabolism. 36. 100966–100966. 23 indexed citations

11.

Du, Qianqian, Zheqiong Tan, Feng Shi, et al.. (2019). PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation. Cancer Science. 110(6). 2050–2062. 82 indexed citations

12.

Liu, Xiaolan, Yueshuo Li, Xinfang Yu, et al.. (2018). Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination. Cell Death and Disease. 9(2). 53–53. 62 indexed citations

13.

Luo, Xiangjian, Can Cheng, Zheqiong Tan, et al.. (2017). Emerging roles of lipid metabolism in cancer metastasis. Molecular Cancer. 16(1). 76–76. 499 indexed citations breakdown →

14.

Hu, Jianmin, Hongde Li, Xiangjian Luo, et al.. (2017). The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications. International Journal of Cancer. 141(9). 1722–1729. 28 indexed citations

15.

Li, Hongde, Sufang Liu, Jianmin Hu, et al.. (2016). Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. International Journal of Biological Sciences. 12(11). 1309–1318. 101 indexed citations

16.

Luo, Xiangjian, Xiaoyun Xu, Fuhai Li, et al.. (2015). A High-content screen identifies compounds promoting the neuronal differentiation and the midbrain dopamine neuron specification of human neural progenitor cells. Scientific Reports. 5(1). 16237–16237. 16 indexed citations

17.

Yang, Lifang, Zhijie Xu, Liyu Liu, et al.. (2013). Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity. Cancer Biology & Therapy. 15(1). 61–68. 36 indexed citations

18.

Deng, Qipan, Xinfang Yu, Lanbo Xiao, et al.. (2013). Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway. Cell Death and Disease. 4(9). e804–e804. 66 indexed citations

19.

Luo, Xiangjian, et al.. (2011). Autofluorescence spectroscopy for evaluating dysplasia in colorectal tissues. Zeitschrift für Medizinische Physik. 22(1). 40–47. 7 indexed citations

20.

Li, Lili, Shanghui Zhou, Xue Chen, et al.. (2008). The activation of p53 mediated by Epstein‐Barr virus latent membrane protein 1 in SV40 large T‐antigen transformed cells. FEBS Letters. 582(5). 755–762. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact